Our research on aptamer-functionalized lipopolymer aided tumor cell-targeted delivery on press

Our paper on Biomaterials "Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma" was featured in multple media and press.

Breakthrough in pediatric cancer fight	香港浸会大学研发在体靶向骨肉瘤的基因编辑递送系统和治疗策略
Biomaterials：CRISPR/Cas9腫瘤基因療法成功開發新靶向系統	香港浸會大學研發在體靶向骨肉瘤的基因編輯遞送系統和治療策略
​Novel targeted delivery system for CRISPR/Cas9	​《Biomaterials》：香港浸会大学为肿瘤基因疗法开发新靶向系统
Chinese medicine scholars develop innovative targeted delivery systeem for treating osteosarcoma	Technique developed to selectively target cancer cells with CRISPR/Cas9
中医学者成功研发在体靶向基因编辑递送系统，有助于治疗恶性骨肉瘤	香港浸會大學中醫藥學院成功研發在體靶向骨肉瘤的基因編輯遞送系統